SA PRO
Free Account
NextCure, Inc.NXTCNASDAQ
LOADING
|||
Switch Symbol:
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 85% recommend buying.

Consensus Rating
Buy
13 analysts·Moderate coverage
85%
Rating Distribution
Strong Buy
00%
Buy
1185%
Hold
18%
Sell
18%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 34% higher.

Bear Case
$15.00
+34%
Consensus
$15.00
+34%
Bull Case
$15.00
+34%
Price Range13 analysts
Low
Consensus
High
$15.00
$15.00
Current Target
Current Price
$11.20
Upside to Target
$3.80

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jul 15, 2025Piper Sandler
NextCure price target lowered to $15 from $36 at Piper Sandler
Target:$15.00
+215.1%from $4.76
Jun 3, 2024Piper Sandler
Piper Sandler Reiterates Overweight Rating on NextCure Inc. (NXTC)
Target:$3.00
+97.4%from $1.52
Nov 3, 2022Piper Sandler
NextCure price target lowered to $6 from $13 at Piper Sandler
Target:$6.00
+139.0%from $2.51

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance